Philip M. Potter

8.0k total citations
128 papers, 6.3k citations indexed

About

Philip M. Potter is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Philip M. Potter has authored 128 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 59 papers in Pharmacology and 33 papers in Computational Theory and Mathematics. Recurrent topics in Philip M. Potter's work include Cholinesterase and Neurodegenerative Diseases (56 papers), Computational Drug Discovery Methods (33 papers) and Cancer therapeutics and mechanisms (27 papers). Philip M. Potter is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (56 papers), Computational Drug Discovery Methods (33 papers) and Cancer therapeutics and mechanisms (27 papers). Philip M. Potter collaborates with scholars based in United States, United Kingdom and Canada. Philip M. Potter's co-authors include Christopher L. Morton, Mary K. Danks, Matthew R. Redinbo, Carol C. Edwards, Janice L. Hyatt, Randy M. Wadkins, M. Jason Hatfield, Monika Wierdl, Sompop Bencharit and Lyudmila Tsurkan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Philip M. Potter

127 papers receiving 6.1k citations

Peers

Countries citing papers authored by Philip M. Potter

Since Specialization

Citations

This map shows the geographic impact of Philip M. Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip M. Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip M. Potter more than expected).

Fields of papers citing papers by Philip M. Potter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip M. Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip M. Potter. The network helps show where Philip M. Potter may publish in the future.

Co-authorship network of co-authors of Philip M. Potter

This figure shows the co-authorship network connecting the top 25 collaborators of Philip M. Potter. A scholar is included among the top collaborators of Philip M. Potter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip M. Potter. Philip M. Potter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping 2018 ·RNA ·Gang Wu, Liying Fan, Michael N. Edmonson, Timothy I. Shaw, Kristy Boggs, John Easton, Michael Rusch, Thomas R. Webb, Jinghui Zhang, Philip M. Potter	31
2	Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance 2016 ·The AAPS Journal ·Upendra A. Argikar, Philip M. Potter, J. Matthew Hutzler, Punit H. Marathe	69
3	Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs 2013 ·Molecular Therapy — Nucleic Acids ·Kazue Kasai, Hiroshi Nakashima, Fang Liu, (unknown), Jiang Wang, Mitch A. Phelps, Philip M. Potter, William F. Goins, Soledad Fernández, E. Antonio Chiocca	9
4	High Payload Dual Therapeutic‐Imaging Nanocarriers for Triggered Tumor Delivery 2012 ·Small ·Jin‐Ki Kim, Hong Yuan, (unknown), (unknown), Markos Leggas, Philip M. Potter, John J. Rinehart, Michael Jay, Xiuling Lü	13
5	The development and application of small molecule modulators of SF3b as therapeutic agents for cancer 2012 ·Drug Discovery Today ·Thomas R. Webb, (unknown), Philip M. Potter	82
6	Carboxylesterase inhibitors 2011 ·Expert Opinion on Therapeutic Patents ·M. Jason Hatfield, Philip M. Potter	103
7	Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanism 2011 ·Journal of Molecular Modeling ·(unknown), (unknown), Delwar Hossain, Monika Wierdl, Steven R. Gwaltney, Philip M. Potter, Randy M. Wadkins	11
8	Biochemical and molecular analysis of carboxylesterase‐mediated hydrolysis of cocaine and heroin 2010 ·British Journal of Pharmacology ·(unknown), Lyudmila Tsurkan, (unknown), (unknown), (unknown), (unknown), (unknown), Philip M. Potter	51
9	Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactones 2010 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Philip W. Connelly, (unknown), Philip M. Potter, John F. Teiber, Graham F. Maguire, Dominic S. Ng	6
10	Modifications of human carboxylesterase for improved prodrug activation 2008 ·Expert Opinion on Drug Metabolism & Toxicology ·(unknown), Monika Wierdl, Randy M. Wadkins, Philip M. Potter	29
11	Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure–activity relationship analysis 2008 ·Bioorganic & Medicinal Chemistry ·Toshiyuki Harada, Yoshiaki Nakagawa, Randy M. Wadkins, Philip M. Potter, Craig E. Wheelock	31
12	Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases 2006 ·Biochemical Pharmacology ·Matthew K. Ross, Abdolsamad Borazjani, Carol C. Edwards, Philip M. Potter	130
13	Development of a Tumor-Selective Approach to Treat Metastatic Cancer 2006 ·PLoS ONE ·Karen S. Aboody, (unknown), Elizabeth Garcia, Marianne Z. Metz, Joseph Najbauer, Kristine A. Justus, Doris A. Phelps, Joanna S. Remack, Karina J. Yoon, (unknown), Seung Up Kim, Carlotta A. Glackin, Philip M. Potter, Mary K. Danks	108
14	Structural Insights into Drug Processing by Human Carboxylesterase 1: Tamoxifen, Mevastatin, and Inhibition by Benzil 2005 ·Journal of Molecular Biology ·Christopher D. Fleming, Sompop Bencharit, Carol C. Edwards, Janice L. Hyatt, Lyudmila Tsurkan, Feng Bai, Charles H. Fraga, Christopher L. Morton, Escher L. Howard-Williams, Philip M. Potter, Matthew R. Redinbo	122
15	Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies. 2003 ·PubMed ·Kyoung Jin P. Yoon, (unknown), Christopher L. Morton, William G. Bornmann, Richard Lee, Philip M. Potter, Mary K. Danks	14
16	p53-Mediated Regulation of Expression of a Rabbit Liver Carboxylesterase Confers Sensitivity to 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Monika Wierdl, Christopher L. Morton, Linda C. Harris, Mary K. Danks, John D. Schuetz, Philip M. Potter	1
17	Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients. 2002 ·PubMed ·Lars M. Wagner, Sylvie M. Guichard, (unknown), Christopher L. Morton, (unknown), Richard A. Ashmun, Linda C. Harris, Peter J. Houghton, Philip M. Potter, Mary K. Danks	27
18	Immunohistological examination of the inter- and intracellular distribution of 06-alkylguanine-DNA-alkyltransferase in human liver and melanoma. 1992 ·UCL Discovery (University College London) ·Siow Ming Lee, (unknown), (unknown), (unknown), Michael Bromley, Martin Harris, Nicholas Thatcher, Philip M. Potter, (unknown), (unknown), T. Cerny, O'Connor Pj, GP Margison	3
19	Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma 1992 ·British Journal of Cancer ·Siow Ming Lee, Joseph A. Rafferty, (unknown), (unknown), Michael Bromley, Martin Harris, N. Thatcher, Philip M. Potter, (unknown), (unknown), Thomas Cerny, O'Connor Pj, GP Margison	45
20	Characterisation and nucleotide sequence ofogt, the O⁶-alkyiguanine-DNA-alkyltransferase gene ofE.coli 1987 ·Nucleic Acids Research ·Philip M. Potter, Mark C. Wilkinson, J.E. Fitton, Francis J. Carr, John Brennand, Donald P. Cooper, Geoffrey P. Margison	143

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact